Hyperpigmentation Disorders Treatment Market Is Seeing Explosive Growth by Future Industry Winners: Forecast, 2020-2027

 The global hyperpigmentation disorders treatment was anticipated to held a market value of USD 3,915 million in the year 2017 and is expected to grow at a CAGR of 7.1% during the forecast period.

Hyperpigmentation disorder are harmless skin condition caused by darkened skin patches. Rising demand for outpatient dermabrasion procedures, increasing adoption of lasers and growing cosmetics expenditure are expected to drive the growth of the market. Additionally, rising R&D spending followed aggressive strategies by the key market players is generating awareness for the disease boosting the market to grow. According to the American Society of Plastic Surgeons, the number of dermabrasion cosmetic procedures have increased from 42,218 in 2000 to 88,182 in 2016 with a 109% increase during the estimated period.

However, factors such as the lack of adequate reimbursement policy and high costs procedures is estimated to restraint the market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7462 

Regional Analysis

The Asia-Pacific are likely to dominate the global hyperpigmentation disorders treatment market.  Rising awareness of hyperpigmentation disorders, presence of rapidly developing healthcare technology, huge patient population, and high healthcare expenditure are some of the factors driving the market. The Americas stood second in the global hyperpigmentation disorders treatment market owing to government funding and support for healthcare sector. Moreover, presence of developed economies like US and Canada provides suitable backgrounds for the market growth. Europe is expected to be the third largest hyperpigmentation disorders treatment market. Following the Europe, the Middle East & Africa is expected to account for the least share of the global hyperpigmentation disorders treatment market.

Segmentation

The global hyperpigmentation disorders treatment market has been segmented based on treatment type, disease indication, end-user, and region.

Based on treatment type, the market has been classified as topical drugs, chemical peels, microdermabrasion, laser therapy, phototherapy, and others. The market, by disease indication, has been segmented into melasma, solar lentigines, post-inflammatory hyperpigmentation, and others. based on end-user, the market has been segmented into hospitals, aesthetic clinics & dermatology centers, and others. The topical drugs segment is expected to hold the largest market share of the hyperpigmentation disorders treatment market, by treatment type, during the forecast period. Also, by disease indication melasma segment register the considerable growth in comparison to other disease indication.

Key Players

Some of the key players in the global hyperpigmentation disorders treatment market Allergan, Inc., Bayer AG, EpiPharm AG, Episciences, Inc., Galderma laboratories (Nestle Skin Health S.A), Obagi Cosmeceuticals LLC, Pierre Fabre, RXi Pharmaceuticals Corporation, SkinCeuticals International, and Vivier Pharma.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/hyperpigmentation-disorders-treatment-market-7462 

Organic and Natural Feminine Care Market Size, Share, Demand, Financial Overview, Key Developments, Swot Analysis and Forecast to 2027

 The global and North America organic and natural feminine care market is anticipated to touch a size of USD 3,990.93 million by 2023, states Market Research Future (MRFR). The market can showcase 7.06% CAGR from 2018 to 2023 (forecast period).

The inclination towards organically derived products by women owing to its biodegradable and skin-friendly nature is likely to bolster the market demand exponentially. This is signified by the sale of non-genetically modified (GMO) organic cotton products. Moreover, the reduced possibility of rashes and low possibility of contracting cancer and other chronic diseases can augur well for the global and North America organic and natural feminine care market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7441 

Menstrual toxic shock syndrome (TSS) has seen an upsurge according to the report by National Center for Biotechnology Information (NCBI). The use of natural feminine care products can reduce the chances of TSS and drive the market demand. Moreover, government policies creating awareness among the public is expected to drive the market growth.

Segmentation Analysis:

The global and North America organic and natural feminine care market is segmented by product and distribution channel.

Among products, sanitary pads accounted for 63.2% share in 2017, followed by tampons (22.3%), panty liners & shields (9.5%), and others (5.0%). Tampons can generate close to USD 971.66 million by 2023 at a CAGR of 8.67% during the forecast period. This can be attributed to the rising numbers of working women, preference of tampons to conduct day-to-day activities, and awareness of menstrual hygiene. Panty liners & shields can exhibit the second-highest CAGR of 7.68% over the assessment period to accumulate close to USD 394.19 million. This can be credited to their heavy use by the working population in developed economies to prevent discomfort.

By distribution channel, supermarkets & hypermarkets accounted for 43.2% share in 2017, followed by retail pharmacies (30.8%), online purchase (17.4%), and others (8.6%). Supermarkets & hypermarkets can register 6.80% CAGR during the assessment period to generate close to USD 1,696.1 million. This can be credited to this particular outlet being preferred by manufacturers to increase their sales in developing economies. But the online purchase segment can showcase a robust CAGR of 8.24% to contribute close to USD 741.77 million by 2023. The preference of using online channels to avoid social stigma issues by women in developing economies is likely to facilitate growth in the segment.

Regional Analysis:

Geographically, the global and North America organic and natural feminine care market is segmented into Europe, Asia Pacific (APAC), North America, South America, and the Middle East & Africa (MEA). APAC accounted for 43.6% share in 2017, followed by North America and South America holding close to 27.7% share, Europe (24.5%), and MEA (4.2%).

The APAC region can accrue close to USD 1,777.63 million by 2023 at a CAGR of 7.47% during the forecast period. Factors of high awareness levels of consumers, demand for high fluid retention products, and health-consciousness levels among the women populace in China, South Korea, and India are projected to drive market growth. Other factors predicted to spur growth include population spurt and efforts by companies to create awareness through Ads.

North America can generate close to USD 850.73 million by 2023 at 7% CAGR during the assessment period. This can be attributed to availability of various options for feminine care products coupled with advertisements targeting the right demographic. Social media channels ensuring the message of menstrual health reaches audiences can boost the regional market revenue.

Europe is predicted to exhibit 7% CAGR to generate revenue worth USD 974.85 million by 2023. This can be attributed to waste disposal concerns with regards to synthetic feminine hygiene products. Investments in research and development for creating recyclable sanitary pads is likely to bode well for the market. Moreover, efforts by governments to solve pharmaceutical logistics and ensure manufacture of low-cost hygiene products can boost the regional organic and natural feminine care market.

Competitive Analysis:

Prime players in the global and North America organic and natural feminine care market include Maxim Hygiene (U.S.), GladRags (U.S.), Purganics (India), The Honest Company Inc. (U.S.), Procter & Gamble (U.S.), Apropos (U.S.), Tosama (Slovenia), Armada & Lady Anion (Australia), Saathi (India), Rael (U.S.), Heyday Care LLP (India), Veeda USA (U.S.), Bodywise Limited (U.K.), and Corman USA Inc. (U.S.).

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/organic-natural-feminine-care-market-7441 

Veterinary Infusion Pumps Market Size, Share, Demand, Financial Overview, Key Developments, Swot Analysis and Forecast to 2027

 The report on the global veterinary infusion pumps suggests a strong growth for the market that would mark rise from its previous valuation of USD 85.9 million in 2017 with a CAGR of 4.9% during the forecast period covering 2018 to 2023. Market Research Future (MRFR) also reveals several growth opportunities like rising demand from pet owners, increasing investment from the government to provide substantial setup, a surge in demand for insurance policies, and others can play a crucial role in taking the global market ahead.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7417 

Segmentation:

MRFR’s attempt to get close to various details of the global veterinary infusion pumps market leads to a segmentation that includes the type and end user. With various dynamics and factors well-recorded, these segments are offering a closer look into the market to ensure a proper understanding of the market growth. 

By type, the study on the veterinary infusion pump market reveals segments like large-volume infusion pump and syringe infusion pump. The large-volume infusion pump segment had the largest market share in 2017 and it is expected to continue its growth following a similar trajectory.

By end user, the report with details on the veterinary infusion pumps market can be segmented into veterinary clinics, veterinary hospitals, and others. The veterinary hospitals segment had the largest market share in 2017 and it is due to the structural benefits in such institutions and increasing funding for the same.

Regional Analysis:

The Americas would retain its market dominance as the regional spending for such moves are substantially higher than in other regions. This is primarily due to the increased funding for the veterinary sector, hike in the inclusion of top technologies, and better investment capacity of the pet owners. The US and Canada would lead the regional growth. The market would be sluggish in South America as several countries are poor in terms of their financial capacity. Europe would mark similar growth due to a hike in research and treatment facilities. The market would also gain acknowledgment in Asia Pacific as countries in these regions are waking up to such advanced procedures and a growing number of pet owners would boost the market growth.

Competitive Landscape:

The global market for veterinary infusion pumps would witness robust growth due to the growing participation from several companies like Jørgen Kruuse A/S (Denmark), Vetland Medical Sales & Services LLC (US), B. Braun Melsungen AG (Germany), Heska Corporation (US), Q Core Medical Ltd (Israel), Grady Medical Systems (US), Burtons Medical Equipment Ltd (UK), SAI Infusion Technologies (US), DRE Veterinary (US), and Leading Edge Veterinary Equipment, Inc. (US). These companies are making progress in terms of establishing their market stand by increasing their time in devising various market strategies. MRFR’s profiling of these companies includes recent steps like mergers, acquisitions, various investments in research and development facilities, expansion plans, and others to ease the understanding of the furthering of the market in the coming years.

Industry News:

In March 2020, the Centre Serene Sea in Crimea announced that they would make considerable efforts to ensure the well-being of aquatic mammals that often wash ashore. The process is now in a stage where they are trying to design a vehicle with all the necessary equipment to support such a mammal. As a part of this, they are planning to equip the car with infusion pumps and other tools to maximize the chance of saving an animal.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/veterinary-infusion-pumps-market-7417 

Dental Lasers Market 2020 Analysis, Industry Size, Share Leaders, Current Status by Major vendors and Trends by Forecast to 2027

 Dental lasers are considered devices that emit coherent light beams, mainly suited to perform oral surgeries. These lasers prevent the need for surgical instruments like coherent light beams, coherent light beams, and handpieces. Dental lasers also offer benefits like less contamination, less trauma, and less bleeding and are being accepted across the globe due to their ability like short healing time, lower light exposure, portability, and does not require anesthesia. The global dental lasers market, as per a report by Market Research Future (MRFR) is touted to register a healthy CAGR of 5.2% during the assessment period (2017-2023).

The increasing number of dental disorders among the global population and surging awareness associated with oral hygiene is considered the key growth stimulants of the dental lasers market. Innovations made in treatment technologies and dental disorders diagnostics are estimated to offer the market a thrust. Advantages like reduced need for sutures and minimized bleeding are likely to encourage the market growth across the globe.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7375 

The rising spending on cosmetic dentistry is predicted to trigger the demand for dental laser equipment. Cosmetic dentistry is experiencing significant growth, especially in developed countries like Europe and North America owing to the high disposable income. As the aging population is prone to tooth decay and gum diseases, the surge in geriatric population suffering from dental disorders will further encourage the market growth in the foreseeable future.

On the contrary, dental lasers are expensive compared to their substitutes like dental drills, which is estimated to deter the market growth.

Global Dental Lasers Market: Segmental Analysis

The dental lasers market has been segmented on the basis of application, product, and end users.

By product, the dental lasers market is segmented into all tissue dental lasers and soft tissue dental lasers. Of these, the soft tissue dental lasers segment will expand at a significant pace due to rising incidences of soft tissue disorders like gingivitis periodontal disorders.

The application segment comprises oral surgery, endodontic treatment, peri-implantitis, implantology, periodontics, and others. Of these, the periodontics segment will gain prominence due to the surging number of periodontics and increasing the spending power of the consumers.

The end users’ segment is segmented into ambulatory surgical units, hospitals & clinics, and academic & research organizations. Of these, the hospitals & clinics segment will gain prominence owing to the high availability of specialized physicians. Increased preferences for diagnosis and treatment at the clinics will further augment the market growth in the segment.

Regional Frontiers

Geographically, the dental lasers market spans across Europe, Asia Pacific, North America, and the Middle East & Africa.

Considering the global scenario, North America is estimated to acquire the lion’s share and dominate the market, mainly due to the surging cases of dental diseases and increased expenditure on healthcare. As per a study by the National Institute of Dental & Craniofacial Research, around 92% of the adults are predicted to suffer from dental diseases. The existence of developed countries like Canada and the U.S. are further likely to influence the market growth in the region.

Europe bags the second spot with 30%-35% of the total market share. The growth of the regional market can be ascribed to the high dental healthcare expenditure, surging penetration of the market players, and increased government support for the dental sector.

The Asia Pacific is estimated to expand at a rapid pace due to the surging geriatric population, increased preferences for minimally invasive surgeries, and soaring awareness regarding dental lasers. The rapid boom in the dental industry has made the region lucrative for market expansion and development. The rising awareness regarding the guaranteed treatment of dental lasers has further encouraged the market growth. In this region, India is likely to experience significant growth due to surging number of dental diseases caused due to high consumption of alcohol, tobacco, and other products. Surging demand for cosmetic dentistry, coupled with the rising medical tourism will propel the market growth in the APAC.

Industry Updates

September 2019: LBP Optics, a supplier of infrared optics and laser mirrors for laser cutting and welding, research and development, military and defense systems, medical and dental lasers, and other, has recently declared that the company has purchased Symons Mirror Technology. The acquisition will enable LBP Optics to manufacture complex shapes like axicons, polygons, aspheric, infrared domes, and others.

Competitive Dashboard

The top players operating in the dental lasers market include Biolase, Inc., AMD Lasers, Convergent Dental, Inc., Cao Group, Inc., Fotona D.D., Danaher Corporation- Kavo Dental GmbH, Millennium Dental Technologies, Inc., Ivoclar Vivadent AG, Syneron Dental Lasers-Syneron Medical Ltd., Sirona Dental Systems, Inc., Zolar Technology & MFG. Co. Inc., and The Yoshida Dental MFG. Co., Ltd.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/dental-lasers-market-7375 

Veterinary Laboratory Testing Market 2020 Analysis, Industry Size, Share Leaders, Current Status by Major vendors and Trends by Forecast to 2027

 The global veterinary laboratory testing market is anticipated to grow at a 10.1% CAGR between 2018-2023, states the new Market Research Future (MRFR) report. Veterinary laboratory testing is the test that is carried out to detect a disease in any animal. The tests are done by collecting tissue samples, feces, and blood of the animal. 

Numerous factors are pushing the growth of the veterinary laboratory testing market. Such factors, according to the new Market Research Future report, include the rise in adoption of pets, favorable funding policies, advancements in healthcare facilities, rising number of veterinary practitioners, rising expenditure on pet insurance, increasing disposable income, and rising prevalence of zoonotic diseases. 

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7326 

On the contrary, lack of awareness regarding veterinary laboratory testing, complications related to the tests, and the high price of veterinary testing are factors that may restrict the veterinary laboratory testing market growth during the forecast period. 

Market Segmentation 

The Market Research Future report offers a complete segmental analysis of the global veterinary laboratory testing market based on end user, product, animal type, and technology. 

By animal type, the veterinary laboratory testing market is segmented into livestock animal and companion animal. The livestock animal segment is again segmented into poultry, pigs, cattle, and others. The companion animal segment is again segmented into horses, cats, dogs, and others. 

By technology, the veterinary laboratory testing market is segmented into urinalysis, molecular diagnostics, hematology, immunodiagnostics, clinical biochemistry, and others. The urinalysis segment is again segmented into urine test strips, urine analyzers, and urinalysis clips and panels/cartridges. The molecular diagnostics segment is again segmented into microarrays, polymerase chain reaction (PCR) tests, and others. The hematology segment is again segmented into hematology analyzers and hematology cartridges. The immunodiagnostics segment is again segmented into immunoassay analyzers, allergen-specific immunodiagnostic tests, lateral flow assays, ELISA tests, and others. The lateral flow assays segment is further segmented into lateral flow strip readers and lateral flow rapid tests. The clinical biochemistry segment is again segmented into blood gas & electrolyte analysis, glucose monitoring, and clinical chemistry analysis. The chemistry analysis segment is further segmented into chemical chemistry analyzers and clinical reagent clips & cartridges. The glucose monitoring segment is further segmented into urine glucose strips, glucose monitors, and blood glucose strips. The blood gas & electrolyte analysis segment is further segmented into blood gas and electrolyte analyzers and blood gas & electrolyte reagent chips and cartridges. 

By product, the veterinary laboratory testing market is segmented into instruments and consumables. 

By end user, the veterinary laboratory testing market is segmented into diagnostic laboratories, research institutes, in-house testing, hospitals and clinics, and others. 

Regional Analysis 

By region, the global veterinary laboratory testing market report covers the latest trends and growth opportunities across North America, Europe, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, North America will remain the driving force in the market during the forecast period. Numerous factors are propelling the growth of the global veterinary laboratory testing market in this region such as advancements in technology in veterinary diagnostics, rising cases of animal disease, growing awareness about laboratory-based diagnostic for pets, and burgeoning demand for animal diagnostic tests that are laboratory-based. 

The global veterinary laboratory testing market in Europe will hold the second-largest share in the market. Numerous factors are propelling the growth of the global veterinary laboratory testing market in this region, such as increasing expenditure on pet insurance, increasing awareness about veterinary laboratory testing, and numerous technological advancements. 

The global veterinary laboratory testing market in the Asia Pacific region will grow at the fastest pace during the forecast period for a huge number of animals, especially goat, buffalo, and cow suffering from different diseases. 

The global veterinary laboratory testing market in the MEA will have favorable growth during the forecast period for the burgeoning demand for veterinary diagnostic equipment that is cost-effective. 

Key Players

Notable players profiled in the global veterinary laboratory testing market report include Zoetis, Inc., Virbac, VCA Inc., Thermo Fisher Scientific, Randox Laboratories, Ltd., Qiagen N.V., Pfizer, Neogen Corporation, Idvet, Idexx Laboratories, Heska Corporation, Henry Schein, Inc., Biomérieux SA, BIOCHECK Inc., and Abaxis, Inc. Key players have incorporated specific strategies to stay head and shoulders above others in the competition, such as collaborations, mergers and acquisitions, new product launches and innovations, research and development activities, joint ventures/partnerships, and more. 

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/veterinary-laboratory-testing-market-7326 

Sleep Testing Services Market Growth, Trends and Value Chain 2020-2027

 The global sleep testing services market is anticipated to hold a market value of USD 5.9 billion in the year 2017 and is expected to grow at a CAGR of 13.2% during the forecast period. Sleep testing services are used to diagnose sleep disorders by recording heart rate, breathing patterns, brain waves, eye movements, leg movements, etc.

Rising prevalence of sleep disorders, increasing awareness about sleep testing services and technological advancements related to sleep testing services are expected to drive the growth in the market over the forecast period. According to an article published in the Psychiatry Research magazine by Science Direct published in July 2018, global prevalence of restless leg syndrome (a sleep disorder) is 14.8%.  However, high costs of the sleep testing services can restrain the market growth over the assessment period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7275 

Regional Analysis

Geographically, the Americas is expected to dominate the global market owing to the high prevalence of various sleep disorders, rising awareness about the sleep testing services. According to an article published by the National Institute of Neurological Disorders and Stroke in July 2018, 135,000 to 200,000 people in the US are affected by narcolepsy, which is a disorder that affects the sleep-wake cycle of a person. Europe is expected to hold the second largest position in the global market owing to the increasing awareness about sleep testing services. Asia-Pacific is expected to be the fastest growing market owing to the rising prevalence of sleep disorders like insomnia, restless leg syndrome, etc. Moreover, the Middle East and Africa region is expected to account for the least market share in the global market.

Segmentation

The global sleep testing services market has been segmented into diagnostic services, treatment monitoring services and end user.

The market, on the basis of diagnostic services, has been segmented into home sleep testing and in-lab sleep testing. In-lab sleep testing is further segmented into electroencephalogram, full polysomnography, CPAP/BiPAP Titration, multiple sleep latency test (MSLT) and maintenance of wakefulness test (MWT).

The global market, on the basis of treatment monitoring services, has been segmented into obstructive sleep apnea, insomnia, restless legs syndrome, circadian rhythm disorders, narcolepsy and rapid eye movement (REM) sleep disorder.

The global sleep testing services market, by end user, has been segmented into hospitals, sleep centers, home care settings and others. The hospitals segments is expected to hold the largest market share owing to high preference of people visiting the hospitals for treating their disorders. Whereas the sleep centers are expected to grow at the fastest market share owing to increasing awareness among patients regarding the sleep centers.

Key Players

Some of the prominent players in the global sleep testing services market are St. Luke's, Medical Service Company, Midwest Sleep Diagnostics, Inc., Sleep Services Australia, Total Sleep Holdings, Inc., GenesisCare, Carolinas Sleep Services, SleepMed, SOVA Sleep Services, SleepWorks, LLC, HomeSleep, LLC and Others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/sleep-testing-services-market-7275 

Substance Abuse Treatment Market – Functional Survey 2027

 Market Overview

Market Research Future (MRFR) believes that the substance abuse treatment market can capture a healthy growth rate of 11.6% over the analysis period (from 2018 to 2023).

Primary Boosters and Challenges

Alcohol consumption, smoking and drug use are some of the most common practices worldwide, given the easy access to these products, lower government restrictions as well as authorized production. The World Health Organization says that over 3 million deaths every year are the result of excessive intake of alcohol. Addiction to drugs, tobacco and alcohol has also been rising among teenagers and women in line with evolving lifestyle and easy availability. A number of researches show that close to 50 disorders are associated with over consumption of these substances, including liver cirrhosis, cancer, depression, immune suppression and dementia. The rise in these disorders across the world has raised the demand for effective substance abuse treatment options.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7230 

The Clinical and Translational Investigation journal’s report in 2015 claimed that over 60% of smokers begin smoking at 13 years of age while more than 90% of the total population starts before they reach 20 years of age. Sensing the burgeoning numbers of substance abusers across the countries, pharmaceutical firms are launching new drugs that help curb the craving among patients. Disulfiram happens to be one of the earliest drugs in the market that controls the acetaldehyde dehydrogenase enzyme and is widely used in alcohol abuse treatment.

Other growth rendering factors include technological innovations in the diagnostics sector, soaring awareness among patients about the available treatment options and the surge in treatment rates as well as improving healthcare infrastructure.

Market Segmentation

The market for substance abuse treatment has been studied extensively in the MRFR report, which has covered a few major segments including abuse type, treatment type and end user.

The various abuse types highlighted in the MRFR study include tobacco/nicotine addiction, drug abuse and alcohol dependence. The largest market is for drug abuse, in view of the surging addiction to opioid among the global population. Drug abuse has emerged as a huge concern in emerging countries like Mexico, Brazil and China, where substance abuse treatment options are in high demand.

Depending on treatment type, the market caters to tobacco/nicotine addiction treatment, drug abuse treatment and alcohol addiction treatment. Tobacco/nicotine addiction market is currently in the lead, owing to the high availability of various types of over-the-counter nicotine replacement products along with the escalating use of prescription opioids as well as illicit drugs.

Residential treatment centres, inpatient treatment centres and outpatient treatment centres are the key market end-users listed in the report. Outpatient treatment centers are witnessing highest preference among the patients, considering the lower costs, higher availability of these services, and the significant convenience.

Regional Status  

Asia Pacific/APAC, Americas, MEA or Middle East & Africa and Europe are the key markets for substance abuse treatment worldwide.

The Americas is spearheading the global market for substance abuse treatment, in view of the soaring number of drug awareness campaigns as well as prevention programs. These campaigns cover spreading awareness among patients to boost the treatment-seeking rate. Rising government intervention with significant funds and initiatives to control distribution of illicit drugs and other substances also favor the regional market. Other growth enhancing factors include burgeoning population of substance abusers and the surge in technical advancements.

Asia Pacific shows the potential to attain the fastest growth rate in the years to come, thanks to the growing efforts by several countries to deal with mounting concerns regarding drug and alcohol abuse. Moreover, government across various countries are spending considerably on promotional campaigns to prevent and treat addiction. Surge in tobacco addiction coupled with the rise in technical advances also elevate the market position in the region. Alcohol dependency and opioid abuse are quite rampant in the region, especially among the lower-class population while mental health issues have become major concerns. This is bound to create a lucrative scenario for the substance abuse treatment market in the coming years.

Eminent Firms

The affluent firms in the global market for substance abuse treatment include Teva Pharmaceuticals, Accord Healthcare, Alkermes Plc, LFB Group, Sanofi Aventis, Mylan Laboratories, Pfizer Inc., Forest Laboratories, Inc., Purdue Pharma LP, Amphastar Pharmaceuticals, Reckitt Benckiser Pharmaceuticals, GlaxoSmithKline Plc., Allergan, Cipla, INSYS Therapeutics, Sun Pharmaceuticals, Lupin, Opiant Technologies, Apotex, Sanquin, BioCorRx, Glenmark, Sterinova, to list a few.

Latest News

March 2021

Atai Life Sciences and DemeRx have been given the green signal by the UK Medicines and Healthcare products Regulatory Agency or MHRA to begin enrolling for a Phase I/II study of ibogaine HCl, which helps with the treatment of opioid use disorder. Atai Life Sciences has invested close to USD 22 million in the joint venture for the development of the psychedelic, which ensures sustained and rapid efficacy in treating OUD.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/substance-abuse-treatment-market-7230